Basilea Pharmaceutica AG carries a market capitalization of 664.63M, placing it among publicly traded companies globally.
| Market Cap | 664.63M |
| Enterprise Value | N/A |
Basilea Pharmaceutica AG's stock has gained approximately 15.35983% over the past 52 weeks. The 50-day moving average sits at 52.39, while the 200-day moving average is 52.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | 15.35983% |
| 50-Day Moving Average | 52.39 |
| 200-Day Moving Average | 52.02 |
| Average Volume (20 Days) | N/A |